Different PEEP Settings of COVID-19 Induced ARDS

NCT ID: NCT04359251

Last Updated: 2020-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-05

Study Completion Date

2020-03-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This was a multi-center prospective study. All consecutive severe cases of COVID-19 whose PO2/FiO2\<300mmHg with invasive ventilation admitted to 5 fixed-point receive COVID-19 patients hospitals in Wuhan from 5 March to 15 March 2020 were included. Epidemiological, clinical data, lung mechanics, artery blood gas test and hemodynamics at three methods to titrate PEEP, optimizing oxygenation, optimizing compliance, ARDSnet. The study was approved by the Ethics Committee of Zhongda Hsopital, Southeast University.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After PEEP titration, PEEP settings could be set by optimizing oxygenation, optimizing compliance, ARDSnet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Mechanical Ventilation Pressure High Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Optimizing oxygenation

Best oxygenation during PEEP titration

Group Type EXPERIMENTAL

Gas exchanges at different PEEP

Intervention Type OTHER

Gas exchanges measurement at different PEEP

Optimizing compliance

Best compliance during PEEP titration

Group Type EXPERIMENTAL

lung mechanics at different PEEP

Intervention Type OTHER

lung mechanics measurement at different PEEP

ARDSnet

PEEP settings according to ARDSnet table

Group Type EXPERIMENTAL

Hemodynamics changes at different PEEP

Intervention Type OTHER

Hemodynamics changes measurement at different PEEP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gas exchanges at different PEEP

Gas exchanges measurement at different PEEP

Intervention Type OTHER

lung mechanics at different PEEP

lung mechanics measurement at different PEEP

Intervention Type OTHER

Hemodynamics changes at different PEEP

Hemodynamics changes measurement at different PEEP

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COVID-19 patients with mechanical ventilation
* PO2/FIO2\<300mmHg
* ages\>18 years

Exclusion Criteria

* pneumothorax
* pregnant
* hemodynamics is unstable
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southeast University, China

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chun Pan

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chun C Pan

Role: STUDY_DIRECTOR

Zhongda hospital, Southeast University, Jiangsu, China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongda Hospital, Southeast University

Nanjing, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Pan C, Lu C, She X, Ren H, Wei H, Xu L, Huang Y, Xia J, Yu Y, Chen L, Du B, Qiu H. Evaluation of Positive End-Expiratory Pressure Strategies in Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021 Jul 20;8:637747. doi: 10.3389/fmed.2021.637747. eCollection 2021.

Reference Type DERIVED
PMID: 34355001 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COVID-19 PEEP titration

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of PEEP Trials on Ventilation-Perfusion Matching in ARDS Patients
NCT06823804 ENROLLING_BY_INVITATION PHASE2/PHASE3